Related Experiment Video
Updated: Jan 16, 2026
10:28
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
5.8K
Dual Antiplatelet Therapy in NSTEMI: Successfully Navigating the DAPT Dilemma
Loreto L Calaquian1, John-Henry L Dean1, Stephanie A Howes1
1Department of Cardiology, San Antonio Uniformed Services Health Education Consortium, San Antonio, Texas, USA.
Summary
Dual Antiplatelet Therapy (DAPT) is crucial for Non-ST Segment Elevation Myocardial Infarction (NSTEMI) patients but increases bleeding risk. Precision medicine helps tailor DAPT to balance these risks, improving patient outcomes.
Area of Science:
- Cardiology
- Pharmacology
- Precision Medicine
Background:
- Non-ST Segment Elevation Myocardial Infarction (NSTEMI) remains a significant cause of death globally.
- Dual Antiplatelet Therapy (DAPT) is standard for NSTEMI but carries a bleeding risk.
- Balancing ischemic event prevention and bleeding risk is critical in NSTEMI management.
Purpose of the Study:
- To explore the role of precision medicine in optimizing DAPT for NSTEMI patients.
- To highlight the importance of tailoring treatment based on individual patient data.
Main Methods:
- Review of current therapeutic strategies for NSTEMI.
- Analysis of risk stratification tools for DAPT.
- Discussion of precision medicine principles in cardiovascular care.
Main Results:
- DAPT effectively reduces recurrent myocardial infarction (MI), stent thrombosis, and cardiovascular death.
- Increased bleeding complications are associated with DAPT.
- Precision medicine offers a framework for personalized NSTEMI treatment.
Conclusions:
- Precision medicine enables tailored DAPT strategies in NSTEMI.
- Optimizing DAPT through patient-specific data minimizes adverse outcomes.
- Personalized care improves efficacy and safety in NSTEMI management.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
01:27Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
01:30Acute Coronary Syndrome I: Introduction
812
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
812
01:27Peripheral Artery Disease III: Interprofessional Care
245
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
245
01:28Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
01:26Angina IV: Management
237
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
237